{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:06:59Z","timestamp":1784020019784,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10549-026-07976-8","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:57:15Z","timestamp":1778741835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of BRCA1\/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgery"],"prefix":"10.1007","volume":"217","author":[{"given":"Sakiko","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-5053","authenticated-orcid":false,"given":"Kumiko","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-7616","authenticated-orcid":false,"given":"Misato","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kajiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2990-185X","authenticated-orcid":false,"given":"Junko","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-4524","authenticated-orcid":false,"given":"Naoki","family":"Kanomata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-8538","authenticated-orcid":false,"given":"Michiko","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-132X","authenticated-orcid":false,"given":"Atsushi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"7976_CR1","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR et al (2006) Prevalence and Predictors of BRCA1 and BRCA2 Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years. Cancer Res 66:8297\u20138308. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0503","journal-title":"Cancer Res"},{"key":"7976_CR2","doi-asserted-by":"publisher","unstructured":"Sokol ES, Pavlick D, Khiabanian H et al (2020) Pan-cancer analysis of BRCA1 and BRCA2 Genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity. JCO Precision Oncol 442\u2013465. https:\/\/doi.org\/10.1200\/PO.19.00345","DOI":"10.1200\/PO.19.00345"},{"key":"7976_CR3","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT et al (2018) Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun 9:4083. https:\/\/doi.org\/10.1038\/s41467-018-06581-8","journal-title":"Nat Commun"},{"key":"7976_CR4","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies. Am J Hum Genet 72:1117\u20131130. https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"7976_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-Analysis of BRCA1 and BRCA2 Penetrance. JCO 25:1329\u20131333. https:\/\/doi.org\/10.1200\/JCO.2006.09.1066","journal-title":"JCO"},{"key":"7976_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"J Clin"},{"key":"7976_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer. N Engl J Med 347:1227\u20131232. https:\/\/doi.org\/10.1056\/NEJMoa020989","journal-title":"N Engl J Med"},{"key":"7976_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J et al (2002) Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. N Engl J Med 347:1233\u20131241. https:\/\/doi.org\/10.1056\/NEJMoa022152","journal-title":"N Engl J Med"},{"key":"7976_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12282-022-01343-3","volume":"29","author":"M Nara","year":"2022","unstructured":"Nara M, Ishihara S, Kitano A et al (2022) Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis. Breast Cancer 29:394\u2013401. https:\/\/doi.org\/10.1007\/s12282-022-01343-3","journal-title":"Breast Cancer"},{"key":"7976_CR10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ijc.32176","volume":"145","author":"SP Bhaskaran","year":"2019","unstructured":"Bhaskaran SP, Chandratre K, Gupta H et al (2019) Germline variation in BRCA1 \/ 2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients. Intl J Cancer 145:962\u2013973. https:\/\/doi.org\/10.1002\/ijc.32176","journal-title":"Intl J Cancer"},{"key":"7976_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jmedgenet-2015-103132","volume":"53","author":"A Kwong","year":"2016","unstructured":"Kwong A, Shin VY, Ho JCW et al (2016) Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries. J Med Genet 53:15\u201323. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103132","journal-title":"J Med Genet"},{"key":"7976_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","volume":"39","author":"TR Rebbeck","year":"2018","unstructured":"Rebbeck TR, Friebel TM, Friedman E et al (2018) Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat 39:593\u2013620. https:\/\/doi.org\/10.1002\/humu.23406","journal-title":"Hum Mutat"},{"key":"7976_CR13","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1016\/j.clbc.2019.07.014","volume":"20","author":"M Co","year":"2020","unstructured":"Co M, Liu T, Leung J et al (2020) Breast Conserving Surgery for BRCA Mutation Carriers\u2014A Systematic Review. Clin Breast Cancer 20:e244\u2013e250. https:\/\/doi.org\/10.1016\/j.clbc.2019.07.014","journal-title":"Clin Breast Cancer"},{"key":"7976_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","volume":"34","author":"M Colleoni","year":"2016","unstructured":"Colleoni M, Sun Z, Price KN et al (2016) Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. JCO 34:927\u2013935. https:\/\/doi.org\/10.1200\/JCO.2015.62.3504","journal-title":"JCO"},{"key":"7976_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ejca.2004.01.017","volume":"40","author":"C Seynaeve","year":"2004","unstructured":"Seynaeve C, Verhoog LC, van de Bosch LMC et al (2004) Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 40:1150\u20131158. https:\/\/doi.org\/10.1016\/j.ejca.2004.01.017","journal-title":"Eur J Cancer"},{"key":"7976_CR16","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1245\/s10434-009-0638-7","volume":"16","author":"CA Garcia-Etienne","year":"2009","unstructured":"Garcia-Etienne CA, Barile M, Gentilini OD et al (2009) Breast-Conserving Surgery in BRCA1\/2 Mutation Carriers: Are We Approaching an Answer? Ann Surg Oncol 16:3380\u20133387. https:\/\/doi.org\/10.1245\/s10434-009-0638-7","journal-title":"Ann Surg Oncol"},{"key":"7976_CR17","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","volume":"24","author":"LJ Pierce","year":"2006","unstructured":"Pierce LJ, Levin AM, Rebbeck TR et al (2006) Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1\/2 -Associated Stage I\/II Breast Cancer. JCO 24:2437\u20132443. https:\/\/doi.org\/10.1200\/JCO.2005.02.7888","journal-title":"JCO"},{"key":"7976_CR18","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1200\/JCO.1999.17.10.3017","volume":"17","author":"BC Turner","year":"1999","unstructured":"Turner BC, Harrold E, Matloff E et al (1999) BRCA1\/BRCA2 Germline Mutations in Locally Recurrent Breast Cancer Patients After Lumpectomy and Radiation Therapy: Implications for Breast-Conserving Management in Patients With BRCA1\/BRCA2 Mutations. JCO 17:3017\u20133024. https:\/\/doi.org\/10.1200\/JCO.1999.17.10.3017","journal-title":"JCO"},{"key":"7976_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10549-014-2890-1","volume":"144","author":"A Valachis","year":"2014","unstructured":"Valachis A, Nearchou AD, Lind P (2014) Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis. Breast Cancer Res Treat 144:443\u2013455. https:\/\/doi.org\/10.1007\/s10549-014-2890-1","journal-title":"Breast Cancer Res Treat"},{"key":"7976_CR20","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/cam4.2836","volume":"9","author":"F Ye","year":"2020","unstructured":"Ye F, Huang L, Lang G et al (2020) Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer Med 9:1903\u20131910. https:\/\/doi.org\/10.1002\/cam4.2836","journal-title":"Cancer Med"},{"key":"7976_CR21","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","volume":"18","author":"LJ Pierce","year":"2000","unstructured":"Pierce LJ, Strawderman M, Narod SA et al (2000) Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1\/2 Mutations. JCO 18:3360\u20133369. https:\/\/doi.org\/10.1200\/JCO.2000.18.19.3360","journal-title":"JCO"},{"key":"7976_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1013867917101","volume":"1","author":"D Eccles","year":"2001","unstructured":"Eccles D, Simmonds P, Goddard J et al (2001) Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Fam Cancer 1:65\u201372. https:\/\/doi.org\/10.1023\/A:1013867917101","journal-title":"Fam Cancer"},{"key":"7976_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdj095","volume":"17","author":"CTM Brekelmans","year":"2006","unstructured":"Brekelmans CTM, Seynaeve C, Menke-Pluymers M et al (2006) Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17:391\u2013400. https:\/\/doi.org\/10.1093\/annonc\/mdj095","journal-title":"Ann Oncol"},{"key":"7976_CR24","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","volume":"43","author":"CTM Brekelmans","year":"2007","unstructured":"Brekelmans CTM, Tilanus-Linthorst MMA, Seynaeve C et al (2007) Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases. Eur J Cancer 43:867\u2013876. https:\/\/doi.org\/10.1016\/j.ejca.2006.12.009","journal-title":"Eur J Cancer"},{"key":"7976_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-009-0685-6","volume":"120","author":"YM Kirova","year":"2010","unstructured":"Kirova YM, Savignoni A, Sigal-Zafrani B et al (2010) Is the breast-conserving treatment with radiotherapy appropriate in BRCA1\/2 mutation carriers? Long-term results and review of the literature. Breast Cancer Res Treat 120:119\u2013126. https:\/\/doi.org\/10.1007\/s10549-009-0685-6","journal-title":"Breast Cancer Res Treat"},{"key":"7976_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-010-1336-7","volume":"127","author":"K Metcalfe","year":"2011","unstructured":"Metcalfe K, Lynch HT, Ghadirian P et al (2011) Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 127:287\u2013296. https:\/\/doi.org\/10.1007\/s10549-010-1336-7","journal-title":"Breast Cancer Res Treat"},{"key":"7976_CR27","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.clbc.2018.09.011","volume":"19","author":"Y-L Xiao","year":"2019","unstructured":"Xiao Y-L, Wang K, Liu Q et al (2019) Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review. Clin Breast Cancer 19:e48\u2013e65. https:\/\/doi.org\/10.1016\/j.clbc.2018.09.011","journal-title":"Clin Breast Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07976-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:29:51Z","timestamp":1784017791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07976-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7976"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07976-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. This study was approved by the Ethics Committee of St. Luke\u2019s International Hospital (protocol number 22-R021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained by an opt-out procedure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study did not contain any individual person\u2019s data in any form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Naoki Kanomata has received research support from Eiken Chemical Co., Ltd., outside the submitted work. Kumiko Kida is an employee of MSD Japan, outside the submitted work. The remaining authors declare no other conflicts of interest related to this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}